1st October 2010 – Men with advanced, multi-drug resistant prostate cancer can survive an average 2.4 months longer when taking the chemotherapy drug, cabazitaxel, according to new research. It’s the first medication to show a survival benefit in patients whose disease has progressed after standard chemotherapy and for whom there are currently no approved treatment [...]

Expertsexpect that the disease will become merely a condition to be managed, similar to diabetes It wasn’t long ago that prostate cancer was a taboo topic in polite society. It was a hushed-up disease that men would suffer quietly. Not any more. From MPs wearing blue-striped ties in support of NDP leader Jack Layton to [...]

Inside a milk duct of a breast, the DNA of a cell is damaged. The damage is not repaired. Yet the abnormal cell does not die. It multiplies. So begins the odyssey of breast cancer. “Cancer cells tend to proliferate much more aggressively than a normal cell,” said Dr. Deborah Toppmeyer, an oncologist and director [...]

An $8 million grant from the National Institutes of Health is improving the University of Guam’s capability to do cancer research and could strengthen the focus of such research in the Pacific. Four local graduate students have received a total $411,000 to fully fund their studies in a variety of cancer issues on Guam. UOG [...]

New Delhi: Men in the National Capital are more likely to suffer from cancer than women, according to a survey conducted by the National Cancer Registry Programme. While Delhi is at the third spot in reporting all kinds of cancer in men, it remains at the fourth spot in reporting all kinds of cancer in [...]